Cystaran Approval History 
- FDA approved: Yes (First approved October 2nd, 2012)
- Brand name: Cystaran
- Generic name: cysteamine hydrochloride
- Company: Sigma-Tau Pharmaceuticals, Inc.
- Treatment for: Cystinosis
Cystaran (cysteamine cysteamine ophthalmic solution) is a cystine-depleting agent indicated for the treatment of corneal cystine crystal accumulation in patients with cystinosis.
FDA Approval History for Cystaran
See also...
Cystaran (cysteamine hydrochloride) Consumer Information
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
